Medicament for reducing risk of cardiovascular events, e.g. cardiac insufficiency, myocardial infarction or angina, in dialysis patients, containing fosinopril as active agent

摘要

The use of fosinopril (or its salt) (I) is claimed in the production of medicaments for reducing the risk of occurence of cardiovascular events in dialysis patients.